As of October 2024, Kaken Pharmaceutical has a market cap of $1.03B. This makes Kaken Pharmaceutical the world's 7735th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $920.70M | 4.47% |
2023 | $881.30M | -13.75% |
2022 | $1.02B | -7.60% |
2021 | $1.11B | 5.65% |
2020 | $1.05B | -34.02% |
2019 | $1.59B | 24.15% |
2018 | $1.28B | -16.41% |
2017 | $1.53B | -6.13% |
2016 | $1.63B | -25.39% |
2015 | $2.18B | 77.79% |
2014 | $1.23B | 47.91% |
2013 | $830.08M | 24.31% |
2012 | $667.74M | 24.24% |
2011 | $537.45M | 3.75% |
2010 | $518.01M | 24.81% |
2009 | $415.04M | -20.04% |
2008 | $519.06M | 26.02% |
2007 | $411.89M | -15.61% |
2006 | $488.06M | 1.09% |
2005 | $482.81M | 36.15% |
2004 | $354.62M | 25.46% |
2003 | $282.65M | 9.13% |
2002 | $259.01M | -30.95% |
2001 | $375.11M | - |